Preliminary findings from our “long COVID” survey with M3 panel members

Last June we surveyed 295 members of our panel, with respondents across Germany, France, UK, Italy, Spain, and the United States. All respondents had previously tested positive with COVID-19 and explain to M3 to consequences they have been through.

28th February - Rare Disease Day

28th  February is Rare  Disease  Day, a reminder that  we  need to work together to inspire hope and change across all health conditions. A rare disease describes  any disorder that affects only a small percentage of the population. Although their disease may be rare, patients and…

How does COVID-19 affect everyday people?

From struggling to find life-essential supplies to postponing events, COVID-19 has created stress for people across America and the world. Over 800 M3 panel members in the US shared how the pandemic has changed how they receive healthcare treatments as…